StockWatch
·

BioRestorative Therapies, Inc.

Ticker: 1505497

values in millions

Revenue & Profit Trend

in millions
RevenueExpenditureNet Profit
-6.87-2.461.956.36Q3 FY23Q1 FY24Q2 FY24Q3 FY24Q1 FY25Q2 FY25Q3 FY25Q1 FY26

Margin Trend

percentage
OPM %NPM %
-102.00-100.67-99.33-98.00Q3 FY23Q1 FY24Q2 FY24Q3 FY24Q1 FY25Q2 FY25Q3 FY25Q1 FY26
PeriodQ1 FY26Q3 FY25Q2 FY25Q1 FY25Q3 FY24Q2 FY24Q1 FY24Q3 FY23
INCOME
Revenue0.02+100.0%0.01-96.7%0.30+900.0%0.03-87.0%0.23+155.6%0.09+125.0%0.04+33.3%0.03
Total Income0.02+100.0%0.01-96.7%0.30+900.0%0.03-87.0%0.23+155.6%0.09+125.0%0.04+33.3%0.03
EXPENSES
Expenditure3.41-8.3%3.72+3.0%3.61-25.3%4.83+91.7%2.52-1.6%2.56-38.2%4.14+31.8%3.14
PROFIT
Net Profit-2.15+29.3%-3.04-14.3%-2.66+50.2%-5.34-389.9%-1.09+73.0%-4.03-81.5%-2.22+24.2%-2.93
KEY METRICS
OPM %-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%
NPM %-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%
EPS-0.12+63.6%-0.33-10.0%-0.30+53.1%-0.64-392.3%-0.13+74.0%-0.50-51.5%-0.33+48.4%-0.64

Corporate Events

Board MeetingBRTX
2026
5Nov

Board Meeting

Esha Randhawa and Jatinder Dhaliwal resigned as directors. D…

SEC Filing ↗
Board MeetingBRTX
2026
7Oct

Board Meeting

Donald J. Currie appointed as a Class I director and to the …

SEC Filing ↗
Board MeetingBRTX
2026
4Sep

Board Meeting

Mr. Silva resigned from his employment with the Company, inc…

SEC Filing ↗
Board MeetingBRTX
2026
26Aug

Board Meeting

Katharyn Field steps down as Interim CEO and CFO; Mika Grass…

SEC Filing ↗
Board MeetingBRTX
2026
13Jul

Board Meeting

Amendments to executive employment agreements and resignatio…

SEC Filing ↗
Board MeetingBRTX
2026
12Jun

Board Meeting

Revolving Loan Agreement entered, leading to the resignation…

SEC Filing ↗
Board MeetingBRTX
2026
10Jun

Board Meeting

Employment Agreement for Francisco Silva, VP, Research and D…

SEC Filing ↗
Board MeetingBRTX
2026
26May

Board Meeting

New employment agreements for President/CEO/Chairman and CFO…

SEC Filing ↗
Board MeetingBRTX
2026
1May

Board Meeting

Compensation Committee approved cash bonuses for executive o…

SEC Filing ↗